Jianping Weng
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Geriatrics and Gerontology top 0.5%
Papers in
-
- Diabetes Management and Research 41
- Diabetes Treatment and Management 31
- Diabetes, Cardiovascular Risks, and Lipoproteins 21
-
- Metabolism, Diabetes, and Cancer 30
- Co-authors
- Suowen Xu (35 shared papers)Weiping Jia (26 shared papers)Wenying Yang (27 shared papers)Zhiguang Zhou (27 shared papers)Linong Ji (15 shared papers)Haoming Tian (18 shared papers)Sihui Luo (68 shared papers)Iqra Ilyas (8 shared papers)
- Journals
- Diabetes/Metabolism Research and Reviews (15 papers)Journal of Diabetes (14 papers)Diabetes (12 papers)Journal of Diabetes Investigation (11 papers)PLoS ONE (9 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Jianping Weng
308 papers receiving 12.7k citations
Jianping Weng's Hit Papers
Peers
Comparison fields: 5 of 161
- Endocrinology, Diabetes and Metabolism 4.0k
- Geriatrics and Gerontology 277
- Physiology 1.1k
- Surgery 1.7k
- Epidemiology 1.3k
Countries citing papers authored by Jianping Weng
This map shows the geographic impact of Jianping Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianping Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianping Weng more than expected).
Fields of papers citing papers by Jianping Weng
This network shows the impact of papers produced by Jianping Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianping Weng. The network helps show where Jianping Weng may publish in the future.
Co-authors
The 25 scholars most cited alongside Jianping Weng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 318 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevalence of Diabetes among Men and Women in China Hit paper breakdown → | 2010 | 2498 |
| 2 | Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies Hit paper breakdown → | 2021 | 752 |
| 3 | The many faces of diabetes: a disease with increasing heterogeneity Hit paper breakdown → | 2013 | 462 |
| 4 | Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2013 | 375 |
| 5 | 2020 | 326 | |
| 6 | Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies Hit paper breakdown → | 2022 | 252 |
| 7 | 2004 | 246 | |
| 8 | 2011 | 230 | |
| 9 | 2018 | 228 | |
| 10 | 2016 | 223 | |
| 11 | 2013 | 212 | |
| 12 | GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential Hit paper breakdown → | 2021 | 206 |
| 13 | 2013 | 197 | |
| 14 | 2010 | 186 | |
| 15 | Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis Hit paper breakdown → | 2022 | 174 |
| 16 | Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies Hit paper breakdown → | 2023 | 160 |
| 17 | 2010 | 135 | |
| 18 | 2013 | 133 | |
| 19 | 2016 | 130 | |
| 20 | 2013 | 129 |
About Jianping Weng
Jianping Weng is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Epidemiology and Genetics, having authored 318 papers that have together received 12.9k indexed citations. Recurring topics across this work include Diabetes Management and Research (41 papers), Pancreatic function and diabetes (35 papers), Diabetes Treatment and Management (31 papers), Metabolism, Diabetes, and Cancer (30 papers), Diabetes and associated disorders (25 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers), Gestational Diabetes Research and Management (16 papers) and Adipose Tissue and Metabolism (13 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.0k citations), Geriatrics and Gerontology (277 citations), Physiology (1.1k citations), Surgery (1.7k citations) and Epidemiology (1.3k citations). Jianping Weng has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Suowen Xu, Weiping Jia, Wenying Yang, Zhiguang Zhou, Linong Ji, Haoming Tian, Sihui Luo, Iqra Ilyas, Juming Lu and Zhongyan Shan. Their work appears in journals such as Diabetes/Metabolism Research and Reviews, Journal of Diabetes, Diabetes, Journal of Diabetes Investigation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.